You are here:

Allergan Ltd

Name SMC ID No Status Sub. Type
 
Bimatoprost (Lumigan®) 07/02 Accepted Full submission
bimatoprost + timolol (Ganfort Unit Dose Preservative Free) 906/13 Restricted Abbreviated Submission
bimatoprost 0.3mg/mL single-dose eye drops (Lumigan UD) 839/13 Restricted Abbreviated Submission
bimatoprost timolol Ganfort 312/06 Accepted Abbreviated Submission
botulinum toxin (Vistabel) 680/11 Not Recommended Non submission
botulinum toxin A (Botox) 692/11 Restricted Resubmission
botulinum toxin type a (Botox) 692/11 Not Recommended Full submission
botulinum toxin type a (Botox) 692/11 Not Recommended Resubmission
botulinum toxin type A (Botox) 986/14 Not Recommended Non submission
botulinum toxin type a (Botox) 916/13 Accepted Full submission
botulinum toxin type A (Botox) 931/13 Restricted Full submission
botulinum toxin type A (Botox®) 931/13 Not Recommended Non submission
Brimonidine/timolol (Combigan®) eye drops 196/05 Accepted Abbreviated Submission
Carbomer 0.25% gel (Liquivisc®) 191/05 Accepted Abbreviated Submission
Clostridium botulinum toxin type A neurotoxin (Botox®) 80/03 Not Recommended Full submission
clostridium botulinum type A neurotoxin (Botox) 80/03 Accepted Resubmission
Clostridium botulinum type A neurotoxin (Botox®) 80/03 Not Recommended Resubmission
dexamethasone (Ozurdex) 652/10 Not Recommended Full submission
dexamethasone (Ozurdex) 652/10 Not Recommended Resubmission
dexamethasone (Ozurdex) 652/10 Restricted Resubmission
dexamethasone (Ozurdex) 1046/15 Accepted Full submission
dexamethasone (Ozurdex) 751/11 Superseded Non submission
eluxadoline (Truberzi) 1292/18 Not Recommended Full submission
epinastine (Relestal) 267/06 Not Recommended Non submission

Back